Medicaid Provider Spending

$1.09 trillion in Medicaid claims data, 2018–2024 · 617K+ providers
Home › CA › BAKERSFIELD › ALAN F DAKAK MD INC

ALAN F DAKAK MD INC

NPI: 1780950543 · BAKERSFIELD, CA 93301 · Pediatrics Physician · NPI assigned 03/27/2012

$12.91M
Total Medicaid Paid
441,807
Total Claims
427,749
Beneficiaries
93
Codes Billed
2018-01
First Month
2024-12
Last Month

Provider Details

Authorized OfficialDAKAK, ALAN (PRESIDENT)
NPI Enumeration Date03/27/2012

Monthly Spending Trend

Yearly Breakdown

YearClaimsTotal Paid
2018 77,454 $1.76M
2019 67,715 $1.77M
2020 53,034 $1.42M
2021 61,191 $1.62M
2022 68,314 $1.96M
2023 61,058 $1.74M
2024 53,041 $2.64M

Billing Codes

CodeDescriptionClaimsBeneficiariesTotal Paid
99213 Office or other outpatient visit for the evaluation and management of an established patient, low complexity 67,545 60,318 $2.78M
99392 Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) 24,601 24,381 $1.39M
99391 Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) 18,797 18,466 $1.14M
99393 Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) 14,720 14,626 $957K
96156 16,643 16,465 $925K
G9920 Screening performed and negative 18,468 18,415 $635K
99214 Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity 8,970 8,685 $556K
99394 Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) 6,230 6,214 $486K
96110 Developmental screening, with scoring and documentation, per standardized instrument 6,499 6,450 $411K
99460 5,794 5,763 $359K
99381 3,861 3,772 $279K
92551 20,608 20,436 $260K
90648 18,952 18,643 $198K
90670 16,455 16,346 $180K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets 2,339 2,289 $156K
90723 14,962 14,757 $155K
99188 7,223 7,152 $152K
90686 13,838 13,569 $149K
99462 3,990 3,441 $129K
90680 11,496 11,292 $123K
90633 10,139 10,020 $110K
99212 Office or other outpatient visit for the evaluation and management of an established patient, straightforward 4,102 3,967 $105K
90710 9,746 9,598 $104K
99173 22,700 22,505 $101K
99383 1,299 1,287 $97K
83655 9,947 9,757 $91K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe 2,420 2,345 $72K
90651 5,580 5,527 $67K
87426 Infectious agent antigen detection, SARS-CoV-2 (COVID-19) 2,116 2,082 $65K
G8510 Screening for depression is documented as negative, a follow-up plan is not required 4,101 4,099 $51K
90696 4,690 4,616 $48K
90700 4,398 4,363 $47K
99382 659 649 $45K
85018 21,760 21,351 $40K
87428 660 637 $38K
99222 Initial hospital care, per day, moderate complexity 408 407 $37K
99384 370 370 $34K
17110 331 273 $31K
D1206 Topical application of fluoride varnish 1,238 1,226 $27K
99211 Office or other outpatient visit for the evaluation and management of an established patient, minimal severity 1,765 1,740 $27K
88720 5,971 5,600 $27K
90677 2,046 1,964 $25K
90734 2,358 2,338 $25K
90715 2,252 2,241 $23K
90620 1,439 1,425 $20K
99215 Prolong outpt/office vis 244 242 $14K
90619 1,115 1,113 $12K
87804 Infectious agent antigen detection by immunoassay; Influenza, each type 1,892 807 $12K
90685 850 838 $10K
90688 731 723 $8K
G9919 Screening performed and positive and provision of recommendations 266 264 $8K
69210 225 218 $8K
G0447 Face-to-face behavioral counseling for obesity, 15 minutes 2,461 2,419 $6K
99232 Subsequent hospital care, per day, moderate complexity 119 83 $5K
51701 48 42 $5K
41010 26 25 $5K
99463 50 50 $5K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 254 243 $4K
99395 Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years 27 27 $4K
96150 1,236 1,223 $4K
81002 2,093 1,996 $3K
G8431 Screening for depression is documented as being positive and a follow-up plan is documented 168 168 $3K
96127 523 523 $3K
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A 388 366 $2K
99204 Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity 24 22 $2K
86580 454 424 $2K
94664 93 88 $1K
90621 69 64 $986.25
99203 Office or other outpatient visit for the evaluation and management of a new patient, low complexity 12 12 $946.68
90381 81 72 $875.25
99441 14 14 $499.52
96111 35 35 $424.80
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m service provided within the previous 7 days nor leading to an e/m service or procedure within the next 24 hours or soonest available appointment; 5-10 minutes of medical discussion 14 14 $350.00
J0696 Injection, ceftriaxone sodium, per 250 mg 52 50 $289.21
97802 196 196 $180.00
90707 24 24 $175.50
90713 13 13 $146.25
90380 15 15 $135.00
G0442 Annual alcohol misuse screening, 5 to 15 minutes 47 47 $132.00
90744 13 13 $105.75
81025 26 26 $72.80
90716 12 12 $51.75
90698 12 12 $45.00
A7015 Aerosol mask, used with dme nebulizer 193 185 $24.44
82962 12 12 $20.00
90672 14 14 $18.00
J7611 Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg 105 99 $17.01
94760 254 241 $13.98
96161 911 911 $3.40
J7699 Noc drugs, inhalation solution administered through dme 106 100 $0.00
J7510 Prednisolone oral, per 5 mg 180 174 $0.00
91300 29 28 $0.00
3008F 1,595 1,595 $0.00